Aduro Biotech

(NASDAQ: ADRO)
Healthcare  |  Biotechnology
0.98 -0.0162 -1.62%
Stock Price | Oct. 23, 2019, 11:23 a.m.
0 Followers
Bid: 0.98
Ask: 0.986
Prev. Close: 0.997
52 Week Low: 0.92
52 Week High: 4.93
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Aduro Biotech Inc is a immunotherapy company focused on the discovery, development and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. Its primary technologies related are to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand. The STING pathway activator technology is designed to activate the intracellular STING receptor. The APRIL is a soluble factor that binds to BCMA and TACI receptors thereby inducing signaling, and is implicated in IgA nephropathy.

Read more Read less

Recently Viewed Tickers

Free Stock Watchlist 09/07/2016

3 years ago

Premium Stock Watchlist 04/22/2016

3 years ago

Premium Stock Watchlist 04/01/2016

3 years ago

Premium Stock Watchlist 03/30/2016

3 years ago
4 years ago